High expression of Linc01559 and GRSF1 in duodenal cancer tissues indicates an increased risk of tumor recurrence and metastasis, suggesting that GRSF1 may represent a potential therapeutic target for duodenal cancer. This evidence concerns the gene GRSF1 and neoplasm.